| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +50K | 0.7% | $1.61 | +$80.3K |
| Sells | 2 | -7.14M | 99.3% | $1.59 | -$11.4M |
| Net | +1 | -7.09M | -98.6% | -$11.3M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Thomas J. Schuetz | CHIEF EXECUTIVE OFFICER, Director | $31.1M | +$21.1K | +0.07% | Nov 16, 2025 |
| Vered Bisker-Leib | CHIEF EXECUTIVE OFFICER, Director | $4.53M | Feb 8, 2024 | ||
| Barry Shin | Cfo | $660K | Feb 11, 2025 | ||
| Neil Lerner | Chief Accounting Officer | $454K | +$28.4K | +6.67% | Apr 7, 2025 |
| Jonathan Anderman | Gen Counsel & Corporate Sec | $32.3K | +$30.8K | +2000% | Apr 7, 2025 |
| Orbimed Advisors Llc | Director, 10%+ Owner | $0 | -$5.68M | -100% | Apr 9, 2025 |
| Carl L. Gordon | Director, 10%+ Owner | $0 | -$5.68M | -100% | Apr 9, 2025 |
| Susan Kalled | Chief Scientific Officer | Feb 18, 2022 | |||
| Richard S. Lindahl | Director | Feb 11, 2025 | |||
| Mary Ann Gray | Director | Feb 11, 2025 | |||
| Brett Kaplan | Director | Feb 18, 2022 | |||
| David M. Wurzer | Director | Feb 8, 2023 | |||
| Stephen P. Squinto | Director | Feb 18, 2022 | |||
| Ellen Chiniara | Director | Feb 11, 2025 | |||
| James P. Boylan | Director | Feb 11, 2025 | |||
| Miranda Jayne Toledano | Director | Jun 25, 2021 | |||
| Philip Ferneau | Director | Feb 11, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|